PharmaTutor (May- 2014)
ISSN: 2347 - 7881
Received On: 03/03/2014; Accepted On: 09/03/2014; Published On: 01/05/2014
Author: S. Chouhan*, P. Sharma, J. Pathak, A. Namdev, M. Sain
Department of Pharmaceutics, Lachoo Memorial College of Science and Technology,
Pharmacy wing; Jodhpur
shailendra.chouhan26@gmail.com
ABSTRACT:
In present era nanoparticles have emerged as an efficient and promising tool in therapeutics and diagnostics. Nanotechnology is a multidisciplinary field it merges basic sciences and applied disciplines like biophysics, molecular biology and bioengineering. Nanotechnology has created impact in various fields of medicine comprising neurology, oncology, immunology, cardiology, endocrinology. Nanotechnology presents revolutionary opportunities for diagnosis and therapy of many diseases. The nanoparticles capable of diagnosis, drug delivery and monitoring of therapeutic response are expected to play a significant role in emergence of era of personalized medicine.
How to cite this article: S Chouhan, P Sharma, J Pathak, A Namdev, M Sain; Engineered Nanocarriers: An Emerging Tool in Therapeutics and Diagnostics; PharmaTutor; 2014; 2(5); 38-50
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Wong HL, Wu XY, Bendayan R: Nanotechnological advances for the delivery of CNS therapeutics. Advanced Drug Delivery Reviews 2012, 64: 686-700.
2. Fayad ZA, Cormode DP, Jarzyana PA, Mulder WJM: Modified natural nanoparticles as contrast agents for medical imaging. Advanced Drug Delivery Reviews 2010, 62: 329-338.
3. Turkevich J, Stevenson PC, Hillier J: A study of the nucleation and growth processes in the synthesis of colloidal gold, Discuss. Faraday Soc 1951, 55–75.
4. Templeton AC, Wuelfing MP, Murray RW: Monolayer protected cluster molecules, Accounts of Chemical Research 2000, 33: 27–36.
5. Uhlmann E, Peyman A: Antisense oligonucleotides — a new therapeutic principle. Chemical Reviews 1990, 90: 543–584.
6. Tsai CY, Shiau AL, Cheng PC, Shieh DB, Chen DH, Chou CH, Yeh CS, Wu CL: A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity. Nano Letters 2004, 4: 1209–1212.
7. Patel DJ, Suri AK, Jiang L, Fan P, Kumar RA, Nonin S: Journal Molecular Biology 1997, 272: 645–664.
8. Mairal T, Özalp VC, Sánchez PL, Mir M, Katakis I, O'Sullivan CK: Analytical and Bioanalytical Chemistry 2008, 390: 989–1007.
9. Jenison RD, Gill SC, Pardi A, Polisky B: High-resolution molecular discrimination by RNA. Science 1994, 263: 1425–1429
10. Bunka DHJ, Stockley PG: Aptamers come of age- At last. Nature Reviews Microbiology 2006, 4: 588–596.
11. Whitesides GM, Mathias JP, Seto CT: Molecular self-assembly and nanochemistry:a chemical strategy for the synthesis of nanostructures. Science 1991, 254: 1312–1319.
12. Lehn JM: Supramolecular chemistry. Science 1993, 260: 1762–1763.
13.Zhang S: Fabrication of novel biomaterials through molecular self-assembly. Nature Biotechnology 2003, 21: 1171–1178.
14. Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH: Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004, 25:1289–1297.
15. Jin HJ, Fridrikh SV, Rutledge GC, Kaplan DL: Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules 2002, 3: 1233–1239.
16. Matthews JA, Wnek GE, Simpson DG, Bowlin GL:Electrospinning of collagen nanofibers. Biomacromolecules 2002, 3:232–238.
17. Park KE, Kang HK, Lee SJ, Min BM, Park WH: Biomimetic nanofibrous scaffolds: preparation and characterization of PGA/chitin blend nanofibers. Biomacromolecules 2006, 7: 635–643.
18. Li WJ, Cooper JJA, Mauck RL, Tuan RS: Fabrication and characterization of six electrospun poly([alpha]-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater 2006, 2: 377–385.
19. Li M, Mondrinos MJ, Chen X, Gandhi MR, Ko FK, Lelkes PI: Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. Journal of Biomedical Materials Research Part A 2006, 79A: 963–973.
20. Huang ZM, Zhang YZ, Kotaki M, Ramakrishna S: A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Composites Science and Technology 2003, 63: 2223–2253.
21. Teo WE, Ramakrishna S: A review on electrospinning design and nanofibre assemblies. Nanotechnology 2006, 17: R89–R106.
22. Reneker DH, Yarin AL. Electrospinning jets and polymer nanofibers. Polymer 2008, 49: 2387–2425.
23. Ma PX: Scaffolds for tissue fabrication. Materials Today 2004, 7: 30–40.
24. Park SH, Kim TG, Kim HC, Yang DY, Park TG: Development of dual scale scaffolds via direct polymer melt deposition and electrospinning for applications in tissue regeneration. Acta Biomater 2008, 4: 1198–1207.
25. Pradhan P, Giri J, Banerjee R, Bellare J, Bahadur D: Cellular interactions of lauric acid and dextran-coated magnetite nanoparticles. Journal of Magnetism of Magnetic Material 2007, 311: 282–287.
26. Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H: Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. Journal of Controlled Release 2004, 98: 317–323.
27. Kogure K, Akita H, Harashima H: Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging. Journal of Controlled Release 2007, 122: 246–251.
28. Kogure K, Akita H, Yamada Y, Harashima H: Multifunctional envelope-type nano device (MEND) as a non-viral delivery system. Advanced Drug Delivery Reviews 2008, 60: 559–571.
29. R.C. Oppenheim, J.J. Marty, P.P. Speiser: Injectable compositions, nanoparticles useful therein, and process of manufacturing same 1978, US 4107288.
30. Chen JF, Wang YH, Guo F, Wang XM, Zheng C: Synthesis of nanoparticles with novel technology: high gravity reactive precipitation. Industrial and Engineering Chemistry Research 2000, 39: 948–954.
31. Johnson BK, Prud'homme RK: Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer. Australian Journal of Chemistry 2003, 56: 1021–1024.
32. Chiou H, Chan HK, Prud'homme RK, Raper JA: Evaluation on the use of confined impinging jets for the synthesis of nanodrug particles. Drug Development and Industrial Pharmacy 2008, 34: 59–64.
33. Chiou H, Chan HK, Heng D, Prud'homme RK, Raper JA: A novel production method for inhalable cyclosporine A powders by confined impinging jet precipitation. Journal of Aerosol Science. 2008, 39: 500–509.
34. Benet N, Muhr H, Plasari E, Rousseaux JM: New technologies for the precipitation of solid particles with controlled properties. Powder Technology 2002, 128: 93–98.
35. Liu Y, Cheng C, Prud'homme RK, Fox RO: Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation. Chemical Engineering Science 2008, 63: 2829–2842.
36. Chen T, D'Addio SM, Kennedy MT, Swietlow A, Kevrekidis IG, Panagiotopoulos AZ, Prud'homme RK: Protected peptide nanoparticles: experiments and brownian dynamics simulations of the energetics of assembly Nano Letters 2009, 9: 2218–2222.
37. Byrappa K, Ohara S, Adschiri T: Nanoparticles synthesis using supercritical fluid technology — towards biomedical applications. Advanced Drug Delivery Reviews 2008, 60: 299–327.
38. Reverchon E, De Marco I, Torino E: Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. Journal of Supercritical Fluids. 2007, 43: 126–138.
39. Luque de Castro MD, Priego-Capote F: Ultrasound-assisted crystallization (sonocrystallization). Ultrasonics Sonochemistry 2007, 14: 717–724.
40. Vidgren MT, Vidgren PA, Paronen TP: Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate. International Journal of Pharmaceutics 1987, 35: 139–144.
41. Chawla A, Taylor KMG, Newton JM, Johnson MCR: Production of spray dried salbutamol sulfate for use in dry powder aerosol formulation. International Journal of Pharmaceutics 1994, 108: 233–240.
42. Eerikäinen H, Watanabe W, Kauppinen EI, Ahonen PP: Aerosol flow reactor method for synthesis of drug nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 2003, 55: 357–360.
43. Jaworek A: Micro- and nanoparticle production by electrospraying. Powder Technology 2007, 176: 18–35.
44. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics 2004. CA- A Cancer Journal for Clinicians 2004, 54: 8–29.
45. Cuenca AG, Jiang HB, Hochwald SN, Delano M, Cance WG, Grobmyer SR: Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006, 107: 459–466.
46. Kogure K, Moriguchi R, Sasaki K, Ueno M, Futaki S, Harashima H: Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. Journal of Controlled Release 2004, 98: 317–323.
47. Bucolo C, Maltese A, Drago F: When nanotechnology meets the ocular surface. Expert Review of Ophthalmology 2008, 3: 325–332.
48. Badawi AA, El-Laithy HM, El Qidra RM, El Mofty H, El Dally M: Chitosan based nanocarriers for indomethacin ocular delivery. Archieves of Pharmacal Research 2008, 31: 1040–1049.
49. Ali M, Byrne ME: Challenges and solutions in topical ocular drug-delivery systems. Expert Review of Clinical Pharmacology 2008, 1: 145–161.
50. Lesniak MS, Brem H: Targeted therapy for brain tumours. Nature Reviews Drug Discovery 2004, 3: 499–508.
51. Ashby LS, Ryken TC: Management of malignant glioma: steady progress with multimodal approaches. Neurosurgical Focus 2006, 20: E3.
52. Gerstenfeld LC, Alkhiary YM, Krall EA, Nicholls FH, Stapleton SN, Fitch JL, Bauer M, Kayal R, Graves DT, Jepsen KJ, Einhorn TA: Three-dimensional reconstruction of fracture callus morphogenesis. Journal of Histochemistry and Cytochemistry 2006, 54: 1215–1228.
53. Mistry AS, Mikos AG: Tissue engineering strategies for bone regeneration. Advances in Biochemical Engineering and Biotechnology 2005, 94: 1–22.
54. Jang JH, Castano O, Kim HW: Electrospun materials as potential platforms for bone tissue engineering. Advanced Drug Delivery Reviews 2009, 61: 1065–1083.
55. Peek LJ, Middaugh CR, Berkland C: Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews 2008, 60: 915–928.
56. De Miguel I, Imbertie L, Rieumajou V, Major M, Kravtzoff R, Betbeder D: Proofs of the structure of lipid coated nanoparticles (SMBV (TM)) used as drug carriers. Pharmaceutical Research 2000, 17: 817–824.
57. Stone A: Microbicides, new approach to preventing HIV and other sexually transmitted infections. Nature Reviews Drug Discovery 2002, 1: 977–985.
58. McCarthy TD, Karellas P, Henderson SA, Giannis M, O'Keefe DF, Heery G, Paull JRA, Matthews GR, Holan G: Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. Molecular Pharmacology 2005, 2: 312–318.
59. Devalapally H, Chakilam A, Amiji MM: Role of nanotechnology in pharmaceutical product development. Journal of Pharmaceutical Sciences 2007, 96: 2547–2565.
60. Singh KK, Vingkar SK: Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. International Journal of Pharmaceutics 2008, 347: 136–143.
61. Smith I: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clinical Microbiology Reviews 2003, 16: 463–496.
62. Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Müller RH, Ehlers S: Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. Journal of Antimicrobial Chemotherapy 2000, 45: 77–83.
63. Mulder WJM, Strijkers GJ, Tilborg GAF van, Griffioen AW, Nicolay K: Lipidbased nanoparticles for contrast-enhanced MRI and molecular imaging. NMR in Biomedicine 2006, 19: 142–164.
64. McCarthy JR, Kelly KA, Sun EY, Weissleder R: Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2007, 2: 153–167.
65. Crich SG, Lanzardo S, Alberti D, Belfiore S, Ciampa A, Giovenzana GB, Lovazzano C, Pagliarin R, Aime S. Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded lowdensity lipoprotein particles. Neoplasia 2007, 9: 1046–1056.
66. Allen M, Bulte JWM, Liepold L, Basu G, Zywicke HA, Frank JA, Young M, Douglas T: Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magnetic Resonance in Medicine 2005, 54: 807–812.
67. Patel DJ, Suri AK, Jiang L, Fan P, Kumar RA, Nonin S: Journal of Molecular Biology 1997, 272: 645–664.
68. Mitchell GP, Mirkin CA, Letsinger RL: Programmed Assembly of DNA Functionalized Quantum Dots. Journal of the American Chemical Society 1999, 121: 8122.
69. Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ: A DNA-Based Method for Rationally Assembling Nanoparticles into Macroscopic Materials. Nature 1996, 382: 607.
70. Ratsimbasoa A, Randriamanantena A, Raherinjafy R, Rasoarilalao N, Ménard D: Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. The American Journal of Tropical Medicine Hygiene 2007, 76: 481–485.
71. Roll D, Malicka J, Gryczynski I, Gryczynski Z, Lakowicz JR: Metallic colloid wavelength-ratiometric scattering sensors. Analytical Chemistry 2003, 75: 3440–3445.
72. Patolsky F, Zheng G, Hayden O, Lakadamyali M, Zhuang X, Lieber CM: Electrical detection of single viruses. Proceedings of the National Academy of Sciences of the United States of America 2004, 101: 14017–14022.
.png)
